Cargando…

Neuropilin-1 Promotes Epithelial-to-Mesenchymal Transition by Stimulating Nuclear Factor-Kappa B and Is Associated with Poor Prognosis in Human Oral Squamous Cell Carcinoma

BACKGROUND: The epithelial-to-mesenchymal transition (EMT) is a key process in carcinogenesis, invasion, and metastasis of oral squamous cell carcinoma (OSCC). In our previous studies, we found that neuropilin-1 (NRP1) is overexpressed in tongue squamous cell carcinoma and that this overexpression i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chu, Weiming, Song, Xiaomeng, Yang, Xueming, Ma, Lu, Zhu, Jiang, He, Mengying, Wang, Zilu, Wu, Yunong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084996/ https://www.ncbi.nlm.nih.gov/pubmed/24999732 http://dx.doi.org/10.1371/journal.pone.0101931

Ejemplares similares

Overexpression of NRP1 is Associated with Poor Prognosis via Accelerating Immunosuppression in Head and Neck Squamous Cell Carcinoma
por: Yang, Xueming, et al.
Publicado: (2023)

Neuropilin-1 predicts poor prognosis and promotes tumor metastasis through epithelial-mesenchymal transition in gastric cancer
por: Jin, Qianna, et al.
Publicado: (2021)

The Role of Neuropilin-2 in the Epithelial to Mesenchymal Transition of Colorectal Cancer: A Systematic Review
por: Lungulescu, Cristina, et al.
Publicado: (2022)

Neuropilin-1 Interacts with Fibronectin-1 to Promote Epithelial–Mesenchymal Transition Progress in Gastric Cancer
por: Wu, Chao, et al.
Publicado: (2020)

Decreased expression of Dlg5 is associated with a poor prognosis and epithelial–mesenchymal transition in squamous cell lung cancer
por: Che, Juanjuan, et al.
Publicado: (2021)

Overexpression of LIMA1 Indicates Poor Prognosis and Promotes Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma
por: Ma, Wei, et al.
Publicado: (2022)

A Circ-0007022/miR-338-3p/Neuropilin-1 Axis Reduces the Radiosensitivity of Esophageal Squamous Cell Carcinoma by Activating Epithelial-To-Mesenchymal Transition and PI3K/AKT Pathway
por: Zhang, Junpeng, et al.
Publicado: (2022)

Plastin3 is associated with epithelial-mesenchymal transition and poor prognosis in gastric cancer
por: Kurashige, Junji, et al.
Publicado: (2019)

Defect of SLC38A3 promotes epithelial-mesenchymal transition and predicts poor prognosis in esophageal squamous cell carcinoma
por: Liu, Rui, et al.
Publicado: (2020)

Neuropilin-2 Expression Promotes TGF-β1-Mediated Epithelial to Mesenchymal Transition in Colorectal Cancer Cells
por: Grandclement, Camille, et al.
Publicado: (2011)

Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer
por: Rachner, Tilman D., et al.
Publicado: (2021)

Cullin 4A is associated with epithelial to mesenchymal transition and poor prognosis in perihilar cholangiocarcinoma
por: Zhang, Tong-Jun, et al.
Publicado: (2017)

Yes-associated protein (YAP) predicts poor prognosis and regulates progression of esophageal squamous cell cancer through epithelial-mesenchymal transition
por: Qu, Yan, et al.
Publicado: (2019)

Neuropilin 1 modulates TGF-β1-induced epithelial-mesenchymal transition in non-small cell lung cancer
por: Ding, Zongli, et al.
Publicado: (2019)

Ubiquitin D Promotes Progression of Oral Squamous Cell Carcinoma via NF-Kappa B Signaling
por: Song, An, et al.
Publicado: (2021)

Epithelial-mesenchymal transition-related gene signature for prognosis of lung squamous cell carcinoma
por: Yu, Hongmin, et al.
Publicado: (2023)

CD47-SIRPα Signaling Induces Epithelial-Mesenchymal Transition and Cancer Stemness and Links to a Poor Prognosis in Patients with Oral Squamous Cell Carcinoma
por: Pai, Shin, et al.
Publicado: (2019)

Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial–mesenchymal transition
por: He, Lu, et al.
Publicado: (2014)

HMGA2 is associated with epithelial–mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma
por: Xia, You-You, et al.
Publicado: (2015)

CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancer
por: Woischke, Christine, et al.
Publicado: (2016)

RASSF6 downregulation promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal cancer
por: Zhou, Rui, et al.
Publicado: (2017)

MACC1 Is Associated With Epithelial–Mesenchymal Transition and Can Predict Poor Prognosis in Nasopharyngeal Carcinoma
por: Cheng, Hao, et al.
Publicado: (2021)

GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma
por: Wang, Guifu, et al.
Publicado: (2020)

Programmed death‐ligand 1 expression at tumor invasive front is associated with epithelial‐mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma
por: Tsutsumi, Satoshi, et al.
Publicado: (2017)

Role of epithelial cell-mesenchymal transition regulators in molecular typing and prognosis of colon cancer
por: He, Shengquan, et al.
Publicado: (2023)

Loss of Neuropilin-2 in Murine Mesenchymal-like Colon Cancer Organoids Causes Mesenchymal-to-Epithelial Transition and an Acquired Dependency on Insulin-Receptor Signaling and Autophagy
por: Poghosyan, Susanna, et al.
Publicado: (2022)

TFIIB-Related Factor 2 Is Associated with Poor Prognosis of Nonsmall Cell Lung Cancer Patients through Promoting Tumor Epithelial-Mesenchymal Transition
por: Tian, Yu, et al.
Publicado: (2014)

lncRNA RMRP predicts poor prognosis and mediates tumor progression of esophageal squamous cell carcinoma by regulating miR-613/ neuropilin 2 (NRP2) axis
por: Xie, Zhen, et al.
Publicado: (2021)

12-lipoxygenase promotes tumor progress by TGF-β1-mediated epithelial to mesenchymal transition and predicts poor prognosis in esophageal squamous cell carcinoma
por: Qu, Yan, et al.
Publicado: (2019)

CD146 Expression Correlates with Epithelial-Mesenchymal Transition Markers and a Poor Prognosis in Gastric Cancer
por: Liu, Wen-Fang, et al.
Publicado: (2012)

Collagen XVII/laminin-5 activates epithelial-to-mesenchymal transition and is associated with poor prognosis in lung cancer
por: Liu, Chen-Chi, et al.
Publicado: (2016)

High Expression of Peroxiredoxin 1 Is Associated with Epithelial-Mesenchymal Transition Marker and Poor Prognosis in Gastric Cancer
por: Yu, Wei, et al.
Publicado: (2018)

High PKD2 predicts poor prognosis in lung adenocarcinoma via promoting Epithelial–mesenchymal Transition
por: Pang, Zhaofei, et al.
Publicado: (2019)

RUFY3 Predicts Poor Prognosis and Promotes Metastasis through Epithelial-mesenchymal Transition in Lung Adenocarcinoma
por: Men, Wanfu, et al.
Publicado: (2019)

MST4 Predicts Poor Prognosis And Promotes Metastasis By Facilitating Epithelial–Mesenchymal Transition In Gastric Cancer
por: Li, Taiyuan, et al.
Publicado: (2019)

Decreased chromobox homologue 7 expression is associated with epithelial–mesenchymal transition and poor prognosis in cervical cancer
por: Tian, Ping, et al.
Publicado: (2021)

ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma
por: Zhang, Huan, et al.
Publicado: (2022)

All‐trans retinoic acid reverses epithelial‐mesenchymal transition in paclitaxel‐resistant cells by inhibiting nuclear factor kappa B and upregulating gap junctions
por: Shi, Guiling, et al.
Publicado: (2018)

Epithelial-Mesenchymal Transition in Oral Squamous Cell Carcinoma
por: Krisanaprakornkit, Suttichai, et al.
Publicado: (2012)

CD44v9 is associated with epithelial‐mesenchymal transition and poor outcomes in esophageal squamous cell carcinoma
por: Taniguchi, Daisuke, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8r3h072k2r0s6pn5u17d2uhjub